How we fund innovative colorectal cancer research
Our research program is a critical driving force in our mission to end colorectal cancer in our lifetime. We've invested nearly $5 million in colorectal cancer research, including nearly $3 million as early-stage grants to innovative researchers. Learn more about how our funding mechanisms guide our investments in colorectal cancer research.
Colorectal cancer is rising in people under 50, and no one knows why. We invest in research that aims to understand more about colorectal cancer in young people and how to prevent it.
Colorectal cancer rates vary among racial groups, age, and socioeconomic status. We support research that helps us understand why and how to improve early detection and treatment among diverse populations.
Nearly 50,000 people with be diagnosed with rectal cancer this year. We awards grants to encourage research in rectal cancer and to establish a successful career path in this field.
Colorectal cancer is one of the few cancers that is preventable. We support researchers studying what motivates people to get screened earlier and detect or prevent this unique cancer.
More survivors are beating colorectal cancer than ever before. However, we still have a long way to go. We need breakthroughs for advanced colorectal cancer and less toxic and more effective cancer treatments.
There is a tremendous unmet need for advancements in screening, treating, and caring for people with colorectal cancer. To foster innovation, we support the training of colorectal cancer researchers.
Our Never Too Young patient and caregiver reports highlight the experiences and needs of the young-onset colorectal cancer community.
We are committed to understanding patient and caregiver barriers to accessing the benefits of biomarker testing, while developing the resources and navigation to assist them.
Support colorectal cancer research
Help make lifesaving research possible. Your gift will be earmarked for the Colorectal Cancer Alliance Chris4Life Research Program.
The American Cancer Society has released its latest insights into cancer trends in the publication "Cancer Statistics, 2024."
The Colorectal Cancer Alliance and its Board of Directors mourn the loss of our esteemed friend and colleague, Dr. Edith Mitchell, MD, MACP, FCCP.
In a critical step forward in the mission to end colorectal cancer (CRC), the nation’s leading CRC nonprofit organization, the Colorectal Cancer Alliance (Alliance), announces the establishment of Project Cure CRC.